Abstract
For many years, the majority of the observational and epidemiological studies assessing coronary artery disease patients, national and international clinical guidelines, registries and randomized trials have focused almost exclusively on men whereas women were usually excluded in most series. This underrepresentation of women in the medical literature in this field has resulted in few data being available regarding the clinical course of the condition, its management and clinical outcomes in this specific population, despite the relatively high prevalence of ischemic heart disease in women. The situation has changed -at least partially- in the past few years with publications focusing on this issue and reporting the existence of inequalities between genders regarding the diagnosis and treatment of coronary heart disease. This article will briefly review gender differences in the clinical presentation, diagnostic strategies and prognosis of coronary heart disease.
Keywords: Coronary artery disease, gender differences, diagnosis, management, epidemiological, nausea, electrocardiogram, angioplasty, pectoris, sotalol, therapeutic, pharmacotherapy, revascularization, proactive, prognostic, angina, invasive, microvascular
Current Pharmaceutical Design
Title: The Importance of Gender Differences in the Diagnosis and Management of Cardiovascular Disease
Volume: 17 Issue: 11
Author(s): Graciana Ciambrone and Juan Carlos Kaski
Affiliation:
Keywords: Coronary artery disease, gender differences, diagnosis, management, epidemiological, nausea, electrocardiogram, angioplasty, pectoris, sotalol, therapeutic, pharmacotherapy, revascularization, proactive, prognostic, angina, invasive, microvascular
Abstract: For many years, the majority of the observational and epidemiological studies assessing coronary artery disease patients, national and international clinical guidelines, registries and randomized trials have focused almost exclusively on men whereas women were usually excluded in most series. This underrepresentation of women in the medical literature in this field has resulted in few data being available regarding the clinical course of the condition, its management and clinical outcomes in this specific population, despite the relatively high prevalence of ischemic heart disease in women. The situation has changed -at least partially- in the past few years with publications focusing on this issue and reporting the existence of inequalities between genders regarding the diagnosis and treatment of coronary heart disease. This article will briefly review gender differences in the clinical presentation, diagnostic strategies and prognosis of coronary heart disease.
Export Options
About this article
Cite this article as:
Ciambrone Graciana and Carlos Kaski Juan, The Importance of Gender Differences in the Diagnosis and Management of Cardiovascular Disease, Current Pharmaceutical Design 2011; 17 (11) . https://dx.doi.org/10.2174/138161211795656945
DOI https://dx.doi.org/10.2174/138161211795656945 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance
Current Vascular Pharmacology Antioxidant Therapy in Diabetic Complications: What is New?
Current Vascular Pharmacology Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design Atrial Fibrillation: Epidemiology and Peculiarities in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Management of Hypertension-Journey from Single Drug Therapy to Multitargeted Ligand Therapy: A Clinical Overview
Current Clinical Pharmacology Appropriate Application of Evidence to the Care of Elderly Patients with Diabetes
Current Diabetes Reviews Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies Neonatal Systemic Thrombosis: An Updated Overview
Current Vascular Pharmacology Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design Bergamot Juice Extract Inhibits Proliferation by Inducing Apoptosis in Human Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?
Current Drug Targets Pharmacological Treatments for Obesity-Related Hypertension
Current Hypertension Reviews Implication of Gut Microbiota in Human Health
CNS & Neurological Disorders - Drug Targets <i>Ajuga</i> L.: A Systematic Review on Chemical Composition, Phytopharmacological and Biological Potential
Current Bioactive Compounds Genetics Talks to Epigenetics? The Interplay Between Sequence Variants and Chromatin Structure
Current Genomics VIP in Inflammatory Bowel Disease: State of the Art
Endocrine, Metabolic & Immune Disorders - Drug Targets Effectiveness of Nasal Continuous Positive Airway Pressure (CPAP) Therapy on Cardiovascular Outcomes in Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
Current Respiratory Medicine Reviews Patents in the Diagnosis and Therapy of Neurocardiogenic Syncope
Recent Patents on Cardiovascular Drug Discovery Molecules from Nature: Modulating the Expression of Estrogen Receptor Genes in Breast Cancer Cells
Current Bioactive Compounds Novel Targets for Antiinflammatory and Antiarthritic Agents
Current Pharmaceutical Design